Management of patients with advanced ovarian cancer – Role of complete cytoreduction and HIPEC: Attitudes of gynaecologist oncologists in two different continents-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Management of patients with advanced ovarian cancer – Role of complete cytoreduction and HIPEC: Attitudes of gynaecologist oncologists in two different continents

Published:2021-02 Issue:1 Volume:61 Page:
ISSN:0004-8666
Container-title:Australian and New Zealand Journal of Obstetrics and Gynaecology
language:en
Short-container-title:Aust N Z J Obstet Gynaecol

Author:

Spiliotis John¹²,Iavazzo Christos³^ORCID,Sugarbaker Paul⁴

Affiliation:

1. Department of Surgical Oncology and HIPEC Athens Medical Centre AthensGreece

2. Department of Surgical Oncology and HIPEC European Interbalkan Medical Centre ThessalonikiGreece

3. Department of Gynecological Oncology Metaxa Cancer Hospital Piraeus Greece

4. MedStar Washington Hospital Center Washington DC USA

Publisher

Wiley

Subject

Obstetrics and Gynecology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajo.13229

Reference5 articles.

1. Peritonectomy and hyperthermic intraperitoneal chemotherapy for advanced epithelial ovarian cancer: What gynaecological oncologists really think

2. Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer

3. Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial

4. Survey on the current gynaecological approach of ovarian cancer patients: The utility of HIPEC

5. TRUST: Trial of Radical Upfront Surgical Therapy in advanced ovarian cancer (ENGOT ov33/AGO‐OVAR OP7)

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRS and HIPEC in a patient with recurrent ovarian cancer after PDS and adjuvant chemotherapy, a case report and MDT discussion;European Journal of Gynaecological Oncology;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3